美股异动 | Parabilis Medicines(PBLS.US)登陆美股市场 开盘后股价涨超44%

智通财经
Yesterday

智通财经APP获悉,周三,聚焦癌症治疗的美国生物科技公司Parabilis Medicines(PBLS.US)登陆美股市场,开盘股价走高,截至发稿,该股涨44.35%,报28.87美元。IPO价格为20美元。Parabilis成立于2015年,专注于开发用于多种癌症及罕见肿瘤的治疗方案。公司拟将IPO募集资金用于推进其最领先候选药物zolucatetide进入更后期临床试验阶段。

截至2025财年年末,Parabilis净亏损1.459亿美元,期末现金及现金等价物2,770万美元;前一财年净亏损为1.179亿美元,现金为4,730万美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10